Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,073 | -19,143 | -23,814 | -16,391 | -12,196 |
| Depreciation Amortization | 192 | 99 | 434 | 330 | 225 |
| Other Working Capital | 173 | 271 | 2,404 | -881 | -868 |
| Other Operating Activity | 14,538 | 15,116 | 3,763 | 2,148 | 1,369 |
| Operating Cash Flow | $-8,170 | $-3,657 | $-17,213 | $-14,794 | $-11,470 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,670 | 2,458 | 12,221 | 10,566 | 5,885 |
| PPE Investments | N/A | N/A | -22 | -22 | -22 |
| Investing Cash Flow | $1,670 | $2,458 | $12,199 | $10,544 | $5,863 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,250 | 520 | 13,335 | 2,048 | 651 |
| Other Financing Activity | -235 | -235 | -128 | -128 | 0 |
| Financing Cash Flow | $3,015 | $285 | $13,207 | $1,920 | $651 |
| Beginning Cash Position | 14,910 | 14,910 | 6,717 | 6,260 | 6,260 |
| End Cash Position | 11,425 | 13,996 | 14,910 | 3,930 | 1,304 |
| Net Cash Flow | $-3,485 | $-914 | $8,193 | $-2,330 | $-4,956 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,170 | -3,657 | -17,213 | -14,794 | -11,470 |
| Capital Expenditure | N/A | N/A | -22 | -22 | -22 |
| Free Cash Flow | -8,170 | -3,657 | -17,235 | -14,816 | -11,492 |